Related Experiment Video
Updated: Jun 11, 2026

DeepOmicsAE: Representing Signaling Modules in Alzheimer's Disease with Deep Learning Analysis of Proteomics, Metabolomics, and Clinical Data
Published on: December 15, 2023
[Could idiosyncratic thinking fit with << omics >>?]
Céline Narjoz1, Philippe Beaune, Isabelle de Waziers
1Université Paris-Descartes et Inserm U775, 75006 Paris, France. celine.narjoz@parisdescartes.fr
Abstract:
Idiosyncratic toxicity is a rare adverse drug-induced reaction. It may occur in a small number of patients, is often serious and may lead to patients' death. Preclinical and clinical drug development fail to predict idiosyncratic post-marketing problems. Idiosyncratic adverse reaction could be prevented either by detection of predisposed patients or use of biomarkers that could predict adverse reactions induced by a drug. The identification of biomarkers that could help predict idiosyncratic reaction requires highthrouhput technologies such as << omics >> (genomic, transcriptomic, proteomic, metabonomic), which are methods allowing screening and evaluation of extensive data and are suitable for untargeted analyses of different models. This review presents genomic and transcriptomic data. The genomic studies identified genetic risk factor that could be used in clinical practice to prevent idiosyncratic reaction in predisposed patients. The transcriptomic studies gave information on biological processes altered by a treatment with a drug. Understanding toxicity mechanisms could lead to identification of toxicity biomarkers.
Insights
Idiosyncratic drug toxicity, though rare, can be fatal. Genomic and transcriptomic studies offer potential biomarkers to predict and prevent these severe adverse drug reactions in susceptible patients.
Area of Science:
- Pharmacogenomics
- Toxicology
- Biomarker Discovery
Context:
- Idiosyncratic toxicity represents rare but severe adverse drug reactions.
- Current preclinical and clinical development methods fail to predict these post-marketing issues.
- Prevention strategies include identifying predisposed individuals and utilizing predictive biomarkers.
Purpose:
- To review genomic and transcriptomic data for predicting idiosyncratic drug reactions.
- To explore the potential of omics technologies in identifying biomarkers for adverse drug events.
- To understand the biological mechanisms underlying drug-induced toxicity.
Summary:
- Genomic studies have identified genetic factors associated with idiosyncratic reactions, enabling clinical risk assessment.
- Transcriptomic studies provide insights into cellular processes affected by drug treatments.
- Integrating these omics data can aid in the discovery of toxicity biomarkers.
Impact:
- Potential to prevent serious adverse drug reactions in susceptible populations.
- Facilitates personalized medicine approaches by identifying at-risk patients.
- Advances the understanding of drug toxicity mechanisms for improved drug safety.
Related Concept Videos
Genomics
Biological Influences on Intelligence
Drug toxicity: Idiosyncratic Reactions
Behavioral Genetics and Its Designs
The primary methodologies used in behavior genetics include family studies, twin studies, and adoption studies, each providing unique...
Pleiotropy
Reason and Intuition